|

Tretinoin Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 2,4,6,8-Nonatetraenoic acid, 3, 7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-, ATRA, Aberel, Airol, Aknoten +28 more

Pipeline

Phase 2: 1

Top Sponsors

  • M.D. Anderson Cancer Center1

Indications

  • Acute Promyelocytic Leukemia With PML-RARA1
  • Cancer1

Houston, Texas1 trial

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

M D Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.